| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| WAY-333908 |
WAY-333908 |
689269-24-7 |
詳細
|
| Dehydroepiandrosterone sulfate |
硫酸脫氫表雄酮 |
651-48-9 |
詳細
|
| Cadazolid |
卡達唑胺 |
1025097-10-2 |
詳細
|
| 5-Hydroxyindole-3-acetic Acid |
5-羥基吲哚-3-乙酸 |
54-16-0 |
詳細
|
| Dimethyl methylsuccinate |
甲基丁二酸二甲酯 |
1604-11-1 |
詳細
|
| 3,4,9,10-Perylenetetracarboxylic diimide |
3,4,9,10－四甲酰二亞胺 |
81-33-4 |
詳細
|
| Roledumab (anti-RHD) |
ROLEDUMAB ( 羅來度單抗 ) |
1174008-79-7 |
詳細
|
| Cy5 DBCO chloride |
CY5 DBCO CHLORIDE |
2182601-72-3 |
詳細
|
| Tesnatilimab (anti-NKG2D) |
特拉佐利單抗 |
2242758-08-1 |
詳細
|
| 1-Boc-5-bromoindoline |
N-BOC-5-溴吲哚啉 |
261732-38-1 |
詳細
|
| Ranibizumab (anti-VEGFA) |
雷尼株單抗 |
347396-82-1 |
詳細
|
| LDC 000067 |
(3-(6-(2-甲氧基苯基)嘧啶-4-基氨基)苯基)甲烷磺酰胺 |
1073485-20-7 |
詳細
|
| WAY-327111 |
4-(4-苯基-6-(三氟甲基)嘧啶-2-基)嗎啉 |
615273-95-5 |
詳細
|
| lineal alkylbenzene |
十二烷基苯(軟型)(直鏈異構(gòu)體的混合物) |
29986-57-0 |
詳細
|
| Datelliptium chloride hydrochloride |
化合物T7747 |
157000-76-5 |
詳細
|
| Flanvotumab (anti-TYRP1) |
Flanvotumab |
1188277-05-5 |
詳細
|
| WAY-326812 |
WAY-326812 |
442898-48-8 |
詳細
|
| Vandortuzumab (anti-STEAP1) |
萬多妥珠單抗 |
1557989-52-2 |
詳細
|
| Galiximab (anti-CD80) |
加利昔單抗 |
357613-77-5 |
詳細
|
| (S)-8-Bromochroman-4-amine hydrochloride |
1810074-67-9 |
1810074-67-9 |
詳細
|
| Mal-PEG1-NHS ester |
馬來酰亞胺-一聚乙二醇-丙烯酸琥珀酰亞胺酯 |
1807518-72-4 |
詳細
|
| 5-(hydroxyphenyl)-10,15,20-phenylporphyrin |
5-(羥苯基)- 10,15,20-苯基卟啉 |
87345-22-0 |
詳細
|
| Amberlyst A21 free base |
阿爾伯特試劑A-21,屬離子交換樹脂 |
9049-93-8 |
詳細
|
| Concizumab (anti-TFPI) |
Concizumab |
1312299-39-0 |
詳細
|
| Tesidolumab (anti-Complement C5) |
Tesidolumab |
1531594-08-7 |
詳細
|
| Xentuzumab (anti-IGF1) |
珍妥珠單抗 |
1417158-65-6 |
詳細
|
| Lacnotuzumab (anti-M-CSF) |
Lacnotuzumab |
1831128-32-5 |
詳細
|
| Ladiratuzumab (anti-SLC39A6) |
LADIRATUZUMAB (ANTI-SLC39A6) |
1629760-28-6 |
詳細
|
| Narsoplimab (anti-MASP2) |
NARSOPLIMAB (納索利單抗 ) |
2108782-45-0 |
詳細
|
| Fluorescein dibenzoate |
熒光素二苯甲酰酯(FDBZ) |
7262-40-0 |
詳細
|
| WAY-328173 |
化合物WAY-328173 |
912790-59-1 |
詳細
|
| WAY-327936 |
N-(苯并[D]噻唑-2-基)-5-氯噻吩-2-磺酰胺 |
620103-74-4 |
詳細
|
| Ethopropazine hydrochloride |
鹽酸乙丙嗪 |
1094-08-2 |
詳細
|
| 2,2,2-Trifluoro-1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethanone |
2,2,2-三氟苯乙酮-4-硼酸頻哪醇酯 |
1004294-77-2 |
詳細
|
| (R)-(-)-1,1'-Bi-2-naphthol Bis(trifluoromethanesulfonate) |
(R)-(-)-1,1'-聯(lián)-2-萘酚二(三氟甲磺酸酯) |
126613-06-7 |
詳細
|
| 8-(Trifluoromethyl)quinoline-5-carboxylic acid |
8-(TRIFLUOROMETHYL)QUINOLINE-5-CARBOXYLIC ACID |
253787-47-2 |
詳細
|
| 4-Bromo-2-fluorobenzaldehyde |
4-溴-2-氟苯甲醛 |
57848-46-1 |
詳細
|
| Chrysophenine |
直接黃 12 |
2870-32-8 |
詳細
|
| Vasicine hydrochloride |
鴨嘴花堿鹽酸鹽 |
7174-27-8 |
詳細
|
| Tisotumab (anti-F3) |
Tisotumab |
1418628-81-5 |
詳細
|
| Vopratelimab (anti-ICOS) |
伏派利單抗 |
2039148-04-2 |
詳細
|
| Ragifilimab (anti-TNFRSF18) |
拉格芙利單抗 |
2207590-51-8 |
詳細
|
| WAY-332052 |
WAY-332052 |
1015858-38-4 |
詳細
|
| N1-methylnicotinamide |
1-METHYLPYRIDIN-1-IUM-3-CARBOXAMIDE |
3106-60-3 |
詳細
|
| Sonepcizumab (anti-Sphingosine-1-phosphate) |
SONEPCIZUMAB (ANTI-SPHINGOSINE-1-PHOSPHATE) |
1031360-18-5 |
詳細
|
| Strong acid cation exchange resin (NA) |
二乙烯基苯與乙烯基苯磺酸鈉的聚合物 |
63182-08-1 |
詳細
|
| Basimglurant |
BASIMGLURANT |
802906-73-6 |
詳細
|
| Biotin-PEG2-acid |
BIOTIN-PEG2-ACID |
1365655-89-5 |
詳細
|
| Methyl 2,4-dioxo-4-phenylbutanoate |
2,4-二羰基苯丁酸甲酯 |
20577-73-5 |
詳細
|
| 3,5-Dimethyl-4-methoxybenzonitrile |
3,5-二甲基-4--甲氧基苯腈 |
152775-45-6 |
詳細
|
| Narnatumab (anti-RON) |
Narnatumab |
1188275-92-4 |
詳細
|
| WAY-330324 |
WAY-330324 |
901031-81-0 |
詳細
|
| (R)-STU104 |
化合物 (R)-STU104 |
2767124-77-4 |
詳細
|
| 4-Chloro-2,6-pyridinedicarboxylic Acid |
4-氯吡啶-2,6-二羧酸 |
4722-94-5 |
詳細
|
| BI-1015550 |
BI-1015550 |
1423719-30-5 |
詳細
|
| Mogamulizumab (anti-CCR4) |
Mogamulizumab |
1159266-37-1 |
詳細
|
| Beef extract desicxant |
牛肉浸粉 |
|
詳細
|
| Rosmantuzumab (anti-RSPO3) |
Rosmantuzumab |
1684393-04-1 |
詳細
|
| Ianalumab (anti-TNFRSF13C) |
Ianalumab |
1929549-92-7 |
詳細
|
| Quetmolimab (anti-CX3CL1) |
QUETMOLIMAB (奎莫利單抗 ) |
2084037-83-0 |
詳細
|
| 2,2-Dimethyl-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one |
2,2-二甲基-2H-吡啶并[3,2-B][1,4]惡嗪-3(4H)-酮 |
20348-21-4 |
詳細
|
| Telazorlimab (anti-TNFRSF4) |
特拉佐利單抗 |
2126777-87-3 |
詳細
|
| Cannabidivarin |
次大麻二酚 |
24274-48-4 |
詳細
|
| Cesium hexafluorophosphate |
六氟磷酸銫 |
16893-41-7 |
詳細
|
| 2′,7′-Bis(2-carboxyethyl)-5(6)-carboxyfluorescein |
2,7-雙(2-羧乙基)-5(6)-羧基熒光素 |
85138-49-4 |
詳細
|
| Apamistamab (anti-PTPRC) |
Iodine (131I) Apamistamab |
2097132-02-8 |
詳細
|
| Sirtratumab (anti-SLITRK6) |
Sirtratumab |
1824663-82-2 |
詳細
|
| Nadecnemab (anti-GFRA3) |
NADECNEMAB (ANTI-GFRA3) |
2377679-19-9 |
詳細
|
| WAY-332068 |
WAY-332068 |
1015864-69-3 |
詳細
|
| 2-Bromophenylacetic acid |
鄰溴苯乙酸 |
18698-97-0 |
詳細
|
| (2-Fluorophenyl)(2-(methylamino)-5-nitrophenyl)methanone |
2-甲氨基-5-硝基-2'-氟二苯甲酮 |
735-06-8 |
詳細
|
| Amberlite IRA-900 |
阿爾伯特試劑 |
9050-97-9 |
詳細
|
| Oxelumab (anti-TNFSF4) |
OXELUMAB ( 奧塞蘆單抗 ) |
1186098-83-8 |
詳細
|
| Zagotenemab (anti-Tau) |
澤格特奈單抗 |
2019133-28-7 |
詳細
|
| Amylopectin from maize |
支鏈淀粉 |
9037-22-3 |
詳細
|
| Bexmarilimab (anti-STAB1) |
BEXMARILIMAB |
2259301-27-2 |
詳細
|
| Lexatumumab (anti-TNFRSF10B) |
來沙木單抗 |
845816-02-6 |
詳細
|
| 3-Fluoro-5-(trifluoromethyl)picolinonitrile |
2-氰基-3-氟-5-三氟甲基吡啶 |
80194-71-4 |
詳細
|
| tert-butyl (1R)-1-amino-3-azabicyclo[3.1.0]hexane-3-carboxylate |
1272757-54-6 |
1272757-54-6 |
詳細
|
| Bivatuzumab (anti-CD44v6) |
比伐珠單抗 |
214559-60-1 |
詳細
|
| Methyl 6-hydroxy-5-nitronicotinate |
6-羥基-5-硝基吡啶-3-甲酸甲酯 |
222970-61-8 |
詳細
|
| Lumiliximab (anti-FceR2) |
LUMILIXIMAB ( 魯昔單抗 ) |
357613-86-6 |
詳細
|
| Vorsetuzumab (anti-CD70) |
Vorsetuzumab |
1165740-62-4 |
詳細
|
| Tamrintamab (anti-DPEP3) |
TAMRINTAMAB (他林妥單抗 ) |
2148325-59-9 |
詳細
|
| Cinpanemab (anti-Alpha-synuclein) |
CINPANEMAB (辛帕奈單抗 ) |
2094516-02-4 |
詳細
|
| Cy5.5 |
熒光染料 |
210892-23-2 |
詳細
|
| Idactamab (anti-SLC1A5) |
IDACTAMAB (ANTI-SLC1A5) |
2245205-37-0 |
詳細
|
| Tusamitamab (anti-CEACAM5) |
特賽妥單抗 |
2349294-95-5 |
詳細
|
| D-Cycloserine |
D-環(huán)絲氨酸 |
68-41-7 |
詳細
|
| DIPHENYLETHOXYMETHYLSILANE |
甲基二苯基乙氧基硅烷 |
1825-59-8 |
詳細
|
| 6,7-Dihydro-2-(2,4,6-trimethylphenyl)-5H-pyrrolo[2,1-c]-1,2,4-triazolium Perchlorate |
6,7-二氫-2-(2,4,6-三甲基苯基)-5H-吡咯并[2,1-C]-1,2,4-三唑鎓高氯酸鹽 |
1334529-08-6 |
詳細
|
| trans-cyclohexane-1,3-dicarboxylic acid |
反式-1,3-環(huán)己烷二甲酸 |
2305-30-8 |
詳細
|
| Itolizumab (anti-CD6) |
伊利組單抗 |
1116433-11-4 |
詳細
|
| Bimagrumab (anti-ACVR2B) |
Bimagrumab |
1356922-05-8 |
詳細
|
| Ravulizumab (anti-Complement C5) |
Immunoglobulin G2/G4, anti-(human complement C5) (human-Mus musculus ALXN1210 heavy chain), disulfide with human-Mus musculus ALXN1210 κ-chain, dimer |
1803171-55-2 |
詳細
|
| KWAR23 (anti-SIRPg) |
KWAR23 (ANTI-SIRPG) |
2243227-60-1 |
詳細
|
| WAY-326432 |
1-[2-[1-(1,3-苯并二氧雜環(huán)戊烯-5-基)-2,5-二甲基吡咯-3-基]-2-氧代乙基]-5-三氟甲基吡啶-2-酮 |
870762-82-6 |
詳細
|
| WAY-327449 |
WAY-327449 |
693240-90-3 |
詳細
|
| WAY-327360 |
WAY-327360 |
687573-14-4 |
詳細
|
| Gadolinium trihydride |
氫化釓 |
37280-14-1 |
詳細
|